Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy [Retraction]
It was recently brought to our attention that a paper published in 2015 by Bin Wei, Qiaoying Huang, Xiaogang Zhong.• Wei B, Huang Q, Zhong X. Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy. OncoTargets and Therapy. 2015;8:1805–1814. P...
Main Authors: | Wei B, Huang Q, Zhong X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/retraction-upregulation-of-nucleostemin-in-colorectal-cancer-and-peer-reviewed-article-OTT |
Similar Items
-
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy
by: Wei B, et al.
Published: (2015-07-01) -
Nucleostemin expression in leukemia patients
by: Hui-Jen Tsai, et al.
Published: (2005) -
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells
by: Shen Jiajie, et al.
Published: (2008-04-01) -
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
by: Okamoto, Naoko, et al.
Published: (2012) -
Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.
by: PLOS ONE Editors
Published: (2020-01-01)